SE469633B - Fysikaliska blandningar av cefalosporinsalter, kristallina sulfatsalter och ett foerfarande foer framstaellning av dessa - Google Patents

Fysikaliska blandningar av cefalosporinsalter, kristallina sulfatsalter och ett foerfarande foer framstaellning av dessa

Info

Publication number
SE469633B
SE469633B SE8603308A SE8603308A SE469633B SE 469633 B SE469633 B SE 469633B SE 8603308 A SE8603308 A SE 8603308A SE 8603308 A SE8603308 A SE 8603308A SE 469633 B SE469633 B SE 469633B
Authority
SE
Sweden
Prior art keywords
mixture
salt
crystalline
zwitterion
acid addition
Prior art date
Application number
SE8603308A
Other languages
English (en)
Swedish (sv)
Other versions
SE8603308L (sv
SE8603308D0 (sv
Inventor
M A Kaplan
T W Hudyma
R A Lipper
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SE8603308D0 publication Critical patent/SE8603308D0/xx
Publication of SE8603308L publication Critical patent/SE8603308L/
Publication of SE469633B publication Critical patent/SE469633B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8603308A 1985-08-05 1986-08-04 Fysikaliska blandningar av cefalosporinsalter, kristallina sulfatsalter och ett foerfarande foer framstaellning av dessa SE469633B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76223585A 1985-08-05 1985-08-05

Publications (3)

Publication Number Publication Date
SE8603308D0 SE8603308D0 (sv) 1986-08-04
SE8603308L SE8603308L (sv) 1987-02-06
SE469633B true SE469633B (sv) 1993-08-09

Family

ID=25064475

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603308A SE469633B (sv) 1985-08-05 1986-08-04 Fysikaliska blandningar av cefalosporinsalter, kristallina sulfatsalter och ett foerfarande foer framstaellning av dessa

Country Status (34)

Country Link
JP (1) JPH0615548B2 (de)
KR (1) KR930003121B1 (de)
AR (1) AR243894A1 (de)
AT (1) AT390957B (de)
AU (1) AU597262B2 (de)
BE (1) BE905219A (de)
CA (1) CA1284994C (de)
CH (1) CH675581A5 (de)
CS (2) CS276849B6 (de)
CY (1) CY1614A (de)
DD (2) DD254941A5 (de)
DE (1) DE3626375A1 (de)
DK (1) DK162053C (de)
EG (1) EG18003A (de)
ES (1) ES2002112A6 (de)
FI (1) FI84484C (de)
FR (1) FR2585705B1 (de)
GB (1) GB2179936B (de)
GR (1) GR862055B (de)
HK (1) HK99691A (de)
HU (1) HU196602B (de)
IE (1) IE59222B1 (de)
IL (1) IL79608A (de)
IT (1) IT1197067B (de)
LU (2) LU88574I2 (de)
MY (1) MY102212A (de)
NL (1) NL8601991A (de)
OA (1) OA08672A (de)
PT (1) PT83134B (de)
SE (1) SE469633B (de)
SG (1) SG79791G (de)
SU (1) SU1516013A3 (de)
YU (1) YU45793B (de)
ZA (1) ZA865842B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988010263A1 (en) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
US4883868A (en) * 1984-12-27 1989-11-28 Banyu Pharmaceutical Co., Ltd. 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives
US4959469A (en) * 1984-12-27 1990-09-25 Banyu Pharmaceutical Company, Ltd. Crystalline cephalosporin compounds
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
JPH02101081A (ja) * 1988-10-08 1990-04-12 Meiji Seika Kaisha Ltd セファロスポリン誘導体結晶性二塩酸塩及びその製造法
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
CA2101571A1 (en) * 1992-09-08 1994-03-09 Elizabeth A. Garofalo Crystalline dihydrate of a cephalosporin dihydrate salt and injectable compositions thereof
EP0638573A1 (de) * 1993-08-10 1995-02-15 Lucky Ltd. Kristalline Hydrate eines Cephalosporins und Verfahren zu ihrer Herstellung
DE602004011685T2 (de) 2003-12-23 2009-02-05 Sandoz Gmbh Verfahren zur herstellung von zwischenprodukten für die verwendung bei der cefalosporinsynthese
WO2008056221A2 (en) * 2006-11-06 2008-05-15 Orchid Chemicals & Pharmaceuticals Limited Crystalline sulfate salt of cephalosporin antibiotic
DE102012101680A1 (de) * 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151588A (en) * 1979-05-14 1980-11-26 Takeda Chem Ind Ltd Preparation of cephalosporin salt crystal
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
US4525473A (en) * 1983-03-30 1985-06-25 Bristol-Myers Company Cephalosporins
DE3419015A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von cephalosporinen
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
GB2165245B (en) * 1984-10-01 1988-05-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
FI84484B (fi) 1991-08-30
SU1516013A3 (ru) 1989-10-15
SG79791G (en) 1991-11-15
ZA865842B (en) 1987-04-29
CS276717B6 (en) 1992-08-12
DK162053B (da) 1991-09-09
AR243894A1 (es) 1993-09-30
HUT41802A (en) 1987-05-28
YU45793B (sh) 1992-07-20
GB2179936B (en) 1989-04-26
PT83134B (pt) 1989-07-31
DK371886D0 (da) 1986-08-04
EG18003A (en) 1991-08-30
DK371886A (da) 1987-02-06
IL79608A0 (en) 1986-11-30
DD254941A5 (de) 1988-03-16
FI84484C (fi) 1991-12-10
BE905219A (fr) 1987-02-04
IE862078L (en) 1987-02-05
AU6069486A (en) 1987-02-12
AT390957B (de) 1990-07-25
CH675581A5 (de) 1990-10-15
LU88574I2 (fr) 1995-03-01
DE3626375A1 (de) 1987-02-12
ATA211086A (de) 1990-01-15
FR2585705B1 (fr) 1989-01-13
GB8618989D0 (en) 1986-09-17
IT1197067B (it) 1988-11-25
MY102212A (en) 1992-05-15
CY1614A (en) 1992-07-10
IT8621409A1 (it) 1988-02-04
KR930003121B1 (ko) 1993-04-19
SE8603308L (sv) 1987-02-06
FR2585705A1 (fr) 1987-02-06
GB2179936A (en) 1987-03-18
ES2002112A6 (es) 1988-07-16
OA08672A (en) 1989-03-31
CA1284994C (en) 1991-06-18
JPS62103090A (ja) 1987-05-13
YU137186A (en) 1987-12-31
HK99691A (en) 1991-12-13
JPH0615548B2 (ja) 1994-03-02
KR880002530A (ko) 1988-05-09
DD268395A5 (de) 1989-05-31
DK162053C (da) 1992-02-10
IE59222B1 (en) 1994-01-26
FI863155A (fi) 1987-02-06
NL8601991A (nl) 1987-03-02
CS276849B6 (en) 1992-08-12
IL79608A (en) 1991-07-18
PT83134A (en) 1986-09-01
FI863155A0 (fi) 1986-08-01
HU196602B (en) 1988-12-28
LU86540A1 (fr) 1987-03-06
GR862055B (en) 1986-12-24
IT8621409A0 (it) 1986-08-04
AU597262B2 (en) 1990-05-31
SE8603308D0 (sv) 1986-08-04

Similar Documents

Publication Publication Date Title
US4910301A (en) Cefepime cephalosporin salts
SE469633B (sv) Fysikaliska blandningar av cefalosporinsalter, kristallina sulfatsalter och ett foerfarande foer framstaellning av dessa
JPH0723382B2 (ja) 結晶質セフエム−酸付加塩およびその製造方法
EP0799232A1 (de) Herstellungsverfahren für cefotaxin und neue salze
BG61368B2 (bg) Моно(2-амониев-2-хидроксиметил-1,3-пропандиол)(2r-сis)- (3-метоксиранил)фосфонат,получаване и фармацевтични състави,които го съдържат
US5244891A (en) Injectable compositions of cefepime dihydrochloride hydrate
US4994451A (en) Cephalosporin salts and injectable compositions
JPH0128744B2 (de)
CS195746B2 (en) Process for preparing crystalline methanolate of natrium salt of cephamandole
US4680389A (en) Temperature stable crystalline di(1-methyl-2-pyrralidinone) and di(N-formylpyrrolidine) adducts of cephalosporin derivatives
KR830000376B1 (ko) 세팔로스포린 화합물의 제조방법
KR840000912B1 (ko) 2, 4-디아미노-5-설파모일 벤젠 설폰산의 제조방법
JPS58183695A (ja) 経口投与用活性セフロキシム誘導体、その製造方法およびその医薬組成物
CA2112196A1 (en) Cephalosporin salts and process for the preparation thereof
HU193045B (en) Process for producing sulfuric acid derivatives

Legal Events

Date Code Title Description
SPCF Application for supplementary protection certificate filed

Free format text: 8603308

SPCG Supplementary protection certificate granted

Free format text: 8603308, EXPIRES: 20080628

NAL Patent in force

Ref document number: 8603308-1

Format of ref document f/p: F

NUG Patent has lapsed